Cloning and Germline Intervention: U.S. Perspectives
By Marcy Darnovsky
| 10. 13. 2003
Perspectives on Reproductive Technologies and Biomedicine
Presentation at The Within and Beyond Human Nature conference, Berlin, Germany
Unlike selective abortion and PGD, the reproductive genetic
procedures on which I'm going to focus today are not being used
in doctors' offices and fertility clinics. No human child has
been produced by means of germline engineering or reproductive
cloning. But the discussion of these possibilities is well underway
in the United States, and that discussion is itself already
shaping our political values and social futures.
I'm going to try in the next few minutes to give you a quick
overview of how germline engineering (or inheritable genetic
modification) and reproductive cloning are being discussed in
the U.S.
First a very brief description of the mainstream advocacy
in the U.S. of these techniques of inheritable genetic modification-that
is, for the production of "enhanced children," or
what the U.S. media often call "designer babies."
Second, some comments on the challenges of convincing U.S.
progressives and feminists that the adoption of these practices
would pose grave threats to their own commitments to social
justice and equality-and that opposing these procedures...
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...